Elevated cell surface PD-L1 and PD-L2 expression by tumor cells is a common strategy conducive to immune escape.380,381 A growing number of antibodies targeting PD-1 and PD-L1 have been developed and approved for clinical use to date. Here, PDCD1LG2 is linked to neoplasm.